Repros Therapeutics Inc. News Headlines

RPRX 
$9.68
*  
3.20
24.84%
Get RPRX Alerts
*Delayed - data as of Sep. 18, 2014 11:32 ET  -  Find a broker to begin trading RPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    RPRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
9/18/2014 8:51:00 AM - Zacks.com

Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline
9/5/2014 12:36:50 PM - Benzinga

Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 4:30:00 PM - Zacks.com

Why Repros Therapeutics Inc. Stock Rocketed Higher
8/28/2014 2:38:06 PM - Motley Fool

Williams-Sonoma Dips On Downbeat Q3 Forecast; Signet Jewelers Shares Jump
8/28/2014 12:42:22 PM - Benzinga

Markets Open Lower; Dollar General Profit Matches Street View
8/28/2014 11:15:37 AM - Benzinga

Why Repros Therapeutics (RPRX) Stock Is Surging Today
8/28/2014 10:00:00 AM - TheStreet

5 Stocks Spiking on Big Volume
8/25/2014 9:26:00 AM - TheStreet

Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% - Tale of the Tape
8/22/2014 9:39:00 AM - Zacks.com

Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog
8/12/2014 10:50:00 AM - Zacks.com

Repros Therapeutics Q2 Loss Widens
8/11/2014 12:35:00 PM - RTT News

Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
7/17/2014 5:20:00 PM - Zacks.com

Repros' Q1 Loss In Line with Expectations - Analyst Blog
5/13/2014 11:00:00 AM - Zacks.com

Commit To Purchase Repros Therapeutics At $12.50, Earn 32.8% Annualized Using Options
4/25/2014 11:44:53 AM - BNK Invest

Monday's ETF Movers: XPH, GDXJ
4/21/2014 2:58:09 PM - BNK Invest

Repros Completes Enrollment for Androxal Study - Analyst Blog
4/15/2014 6:15:01 PM - Zacks.com

Repros Provides Proellex Update - Analyst Blog
3/18/2014 5:10:01 PM - Zacks.com

Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
3/14/2014 9:50:01 AM - Zacks.com

Data on Repros' Androxal - Analyst Blog
2/11/2014 7:26:01 PM - Zacks.com

Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape
2/10/2014 10:46:01 AM - Zacks.com

Repros Shares Soar After FDA Meeting - Analyst Blog
2/7/2014 11:27:01 AM - Zacks.com

Can the Rally in Repros Therapeutics (RPRX) Shares Continue? - Tale of the Tape
1/16/2014 7:43:01 AM - Zacks.com

Repros Continues to Gain on Androxal News - Analyst Blog
1/13/2014 6:00:01 PM - Zacks.com

Loss Narrows at Repros, Shares Down - Analyst Blog
11/11/2013 12:50:01 PM - Zacks.com

Update on Repros' Pipeline - Analyst Blog
11/6/2013 8:05:24 PM - Zacks.com